Insider trades
Jason Hsu, Director of Immix Biopharma IMMX, has filed 13 purchases and 0 sales on the open market. The latest trade was on 05/22.
Jason Hsu
Director
- Company
- Immix Biopharma IMMX
- First filing
- 23/08/14
- Trades
- 20 trades
- Buys / sales
- 13 / 0
- 12-month net buying
- No record
- Last trade
- 05/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
IMMX | Open-market buy | 24/12/20–24/12/23 | 24/12/26 | 47,700 sh2 trades | $2.19avg. | $104,309 | +5.6% |
IMMX | Open-market buy | 24/08/21–24/08/22 | 24/08/26 | 23,100 sh2 trades | $2.24avg. | $51,675 | +2.8% |
IMMX | Open-market buy | 24/07/18–24/07/24 | 24/07/31 | 9,200 sh2 trades | $2.12avg. | $19,524 | +1.1% |
IMMX | Open-market buy | 23/12/08–23/12/11 | 23/12/12 | 56,000 sh2 trades | $4.76avg. | $266,770 | +7.4% |
IMMX | Open-market buy | 23/09/11–23/09/15 | 23/09/18 | 72,000 sh4 trades | $2.78avg. | $200,380 | +10.5% |
Immix BiopharmaIMMX | Open-market buy | 23/09/08 | 23/09/12 | 10,000 sh | $2.53 | $25,300 | +1.5% |